CDMO Andelyn Biosciences says that it has manufactured a viral vector with its AAV Curator ® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program. The Adeno ...
LONDON & NEW YORK--(BUSINESS WIRE)--ViroCell Biologics (“ViroCell” or the “Company”), a specialist viral vector Contract Development and Manufacturing Organisation (“CDMO”) for cell and gene therapy ...
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...
Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy. Among RNA-based ...
Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
The vector consists of a polyethylene glycolylated liposomal outer coat (providing immune evasion and prolonged circulation), a spindle-shaped nanomotor (resembling a flagellum, facilitating targeted ...
Virus-associated cancers are a significant and persistent global health challenge, providing unique insight into the relationship between chronic infection ...
Even tumor cells can be infected by pathogens. In fact, they are especially vulnerable—a side effect of their ability to hide from the immune system. Dr. Jennifer Altomonte and her team at Fusix ...
The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results